Actavis means FTC never should have sued, says 1-800 Contacts counsel
A Supreme Court ruling on the scope of antitrust liability for allegedly anticompetitive pharmaceutical patent settlements should have precluded a Federal Trade Commission challenge to how 1-800 Contacts resolved its trademark disputes, the company's lawyer argued last week.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10